The Epidemiological Aspects of Tuberculosis in Hamadan Province during 2005–11

Document Type: Original Article

Authors

1 Department of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran

2 Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran

3 Center for Disease Control & Prevention, Deputy of Health Services, Hamadan University of Medical Sciences, Hamadan, Iran

Abstract

Background
Epidemiological information on tuberculosis (TB) is required to plan control and prevention strategies and to inform service delivery systems. The aim of present study was to determine the epidemiological status of TB in Hamadan Province covering a seven-year period.
 
Methods
In this cross-sectional study all registered TB patients suffering from any form of smear-positive, smear-negative or extra pulmonary from 2005 to 2011 were assessed. Age-adjusted incidence trend was studied. The Cochran-Armitage (C-A) test was used for testing the trends over time.
 
Results
The mean age of TB patients was 57.0 (±21.1), 49.9% were males, 52.8% were aged 61 years or older and 39.7% were rural residents. Previous history of jailed was present in 13 (2.2%) patients and 12 (2.0%) were HIV positive. From all TB patients, 60.8% were smear-positive, 87.6% were new cases, and 87.3% of smear-positive patients were cured cases. Also, 23.6% patients had history of hospitalization for TB. More than half (55.4%) of TB patients were reported by public health system. Age-adjusted incidence rates of all TB cases during 2005–11 was 3.4, 3.2, 3.6, 4.7, 3.3, 4.4 and 7.3 in 100,000 respectively (C-A trend test, P< 0.001).
 
Conclusion
Although, the incidence rate of TB in Hamadan Province is lower than country’s average, increasing trend of TB incidence is not concordant with its decreasing trend in Iran. An epidemiological study is required to evaluate risk factors associated with TB to identify ways to decrease the prevalence of TB.

Keywords

Main Subjects


1.  World Health Organization (WHO). Tuberculosis. Geneva: WHO; 2013.

2.  Center for Disease Control and Prevention, Ministry of Health and Medical  Education,  Iran.  Tuberculosis  status  [Internet].   2012. Available  from:  http://www.cdc.hbi.ir/TB_Situation_in_Iran.aspx.

3.  World Health Organization (WHO). The global plan to stop TB 2011-2015: Transforming the fight towards elimination of tuberculosis. Geneva: WHO; 2010.

4.  Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasitol 2006; 5:  415–31.

5.  World  Health  Organization  (WHO). Global tuberculosis report 2012.  Geneva:  WHO;  2012.

6.  Hassanzadeh  J,  Nasehi  M,  Rezaianzadeh  A,  Tabatabaee  H, Rajaeifard A, Ghaderi E. Pattern of reported tuberculosis cases in Iran  2009-2010. Iran J Public Health 2013;  42:  72–8.

7.  Marjani M, Baghaei P, Tabarsi P, Shamaei M, Mansouri D, Masjedi MR, et al.  Drug  resistance  pattern  and  outcome  of  treatment  in recurrent episodes of tuberculosis. East Mediterr Health J2012; 18:  957–61.

8.  Nasehi M, Hassanzadeh J, Rezaianzadeh A, Zeigami B, Tabatabaee H,  Ghaderi  E.  Diagnosis  delay  in  smear  positive  tuberculosis patients. J Res Med Sci2012; 17: 1001–4.

9.  Moradi  M,  Arababadi  MK,  Hassanshahi  G.  Tuberculosis  in  the Afghan Immigrants in Kerman Province of Iran. J Biol Sci2008; 8:  1107–9. doi: 10.3923/jbs.2008.1107.1109

10.  World  Health  Organization  (WHO). Treatment of Tuberculosis: Guidelines.  Geneva:  WHO;  2010.

11.  World  Health  Organization (WHO). Global tuberculosis control: WHO report 2011.  Geneva: WHO; 2011.

12.  Salek S, Salek S, Emami H, Masjedi MR, Velayati AA. [Epidemiologic Status of Tuberculosis in Golestan Province]. Tanaffos2008; 7: 63–8.

13.  Haghdoost AA, Mostafavi E, Mirzazadeh A, Navadeh S, Feizzadeh A,  Fahimfar  N, et al.  Modelling  of  HIV/AIDS  in  Iran  up  to  2014. JAHR2011; 3: 231–9.

14.  Muniz  JN,  Ruffino-Netto  A,  Villa  TC,  Yamamura  M,  Arcencio R,  Cardozo-Gonzales  RI.  Epidemiological  aspects  of  human immunodeficiency virus/tuberculosis co-infection in Ribeirão Preto, Brazil  from  1998  to  2003. J Bras Pneumol 2006;  32:  529–34. doi: http://dx.doi.org/10.1590/S1806-37132006000600010

15.  Liu  J,  Lü  B,  Yan  Y.  Meta  analysis  on  the  co-infection  between Mycobacterium tuberculosis and HIV/AIDS in China. Zhonghua Liu Xing Bing Xue Za Zhi 2013; 34: 85–90.

16.  Chehab  JC,  Vilakazi-Nhlapo AK,  Vranken  P,  Peters A,  Klausner JD. Current Integration of Tuberculosis (TB) and HIV Services in South Africa, 2011. PLoS One2013; 8: e57791. doi: 10.1371/journal.pone.0057791

17.  Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P,  Shearer  S.  HIV  and  pulmonary  tuberculosis:  the  impact  goes beyond those infected with HIV. AIDS2004; 18: 657–62.

18.  Rezaeian  S,  Esmailnasab  N.  Social  Determinants  of  Health Associated with Self-Reported HIV Testing among Women. Iran J Public Health 2013;  42:  436–42.

19.  Kaboru BB, Ogwang BA, Namegabe EN, Mbasa N, Kabunga DK, Karafuli K. TB/HIV co-infection care in conflict-affected settings: a mapping of health facilities in the Goma area, Democratic Republic of Congo. Int J Health Policy Manag 2013; 1: 207–11. doi: 10.15171/ijhpm.2013.38

20.  Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, Warndorff D,et al. Investigation of the risk factors for tuberculosis: a casecontrol  study  in  three  countries  in  West  Africa. Int J Epidemiol 2005;  34:  914–23.

21.  Atre S, Kudale A, Morankar S, Gosoniu D, Weiss MG. Gender and community views of stigma and tuberculosis in rural Maharashtra, India. Glob Public Health2011; 6: 56-71. doi: 10.1080/17441690903334240

22.  Liberato  IR,  de Albuquerque  Mde  F,  Campelo AR,  de  Melo  HR. Characteristics of pulmonary tuberculosis in HIV seropositive and seronegative patients in a Northeastern region of Brazil. Rev Soc Bras Med Trop2004; 37: 46–50. doi: http://dx.doi.org/10.1590/S0037-86822004000100012

23.  Codlin AJ, Khowaja S, Chen Z, Rahbar MH, Qadeer E, Ara I, et al. Short report: gender differences in tuberculosis notification in Pakistan. Am J Trop Med Hyg2011; 85: 514–7.

24.  Glynn  JR,  Crampin  AC,  Yates  MD,  Traore  H,  Mwaungulu  FD, Ngwira  BM, et al.  The  importance  of  recent  infection  with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi. J Infect Dis 2005;  192:  480–7. doi: 10.1086/431517

25.  Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, et al. Improving tuberculosis control through public-private collaboration in India: literature review.BMJ2006; 332: 574–8.

26.  Sehgal S, Dewan PK, Chauhan LS, Sahu S, Wares F, Granich R. Public-private  mix  TB  activities  in  Meerut,  Uttar  Pradesh,  North India: delivering dots via collaboration with private providers and non-governmental organizations.Indian J Tuberc2007; 54: 79–83.

27.  Masjedi  MR,  Fadaizadeh  L,  Taghizadeh  Asl  A.  Notification  of patients with tuberculosis detected in the private sector, Tehran, Iran. Int J Tuberc Lung Dis 2007;  11:  882–6.